ESR1 and breast carcinoma: Since ERα has been shown to suppress EMT, efforts to elucidate the molecular mechanisms by which ERα regulates EMT, as well as inhibits stemness, in breast cancer are warranted in order to develop novel treatments for this common type of cancer.